INGN 8-K 2026-11-05

Inogen Inc (INGN) 8-K dated 2026-11-05 — accession 0001294133-26-000040.

Inogen Inc (INGN) is a medical devices company listed on US.

Inogen Inc filed a 8-K on 2026-11-05. Accession 0001294133-26-000040.

This 8-K covers: Acquisition or disposition (Item 2.01), Results of operations (Item 2.02), Director/officer change (Item 5.02), Reg FD disclosure (Item 7.01), Other events (Item 8.01), Exhibits (Item 9.01). SEC EDGAR holds the official filing and its exhibits.

Latest reported INGN revenue for 2025-12-31 was $348.7M. Net income was -$22.7M. Revenue was up 3.9% from 2024-12-31 to 2025-12-31. INGN currently screens at market cap $173.5M.

Not investment advice. The INGN SEC hub lists recent forms. The stock page is the research view.